THE QUESTION OF FK506 NEPHROTOXICITY AFTER LIVER-TRANSPLANTATION

被引：0
作者：
MCCAULEY, J
TAKAYA, S
FUNG, J
TZAKIS, A
ABUELMAGD, K
JAIN, A
TODO, S
STARZL, TE
机构：
[1] VET ADM MED CTR,PITTSBURGH,PA
[2] UNIV PITTSBURGH,CTR HLTH,SCH MED,DEPT MED,PITTSBURGH,PA 15260
来源：
TRANSPLANTATION PROCEEDINGS | 1991年 / 23卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1444 / 1447
页数：4
相关论文
共 50 条
  • [41] Does FK506 (Tacrolimus) Induce Hypertrophic Cardiomyopathy? Comparing Echocardiographic Findings of Children on FK506 and Cyclosporine after Orthotopic Liver Transplantation
    Ruey-Kang R Chang
    Janeth Ceja
    Morris Salem
    Juan Alejos
    Sue McDiarmid
    Pediatric Research, 1999, 45 : 21 - 21
  • [42] ADVERSE-EFFECTS OF FK-506 OVERDOSAGE AFTER LIVER-TRANSPLANTATION
    ALESSIANI, M
    CILLO, U
    FUNG, JJ
    IRISH, W
    ABUELMAGD, K
    JAIN, A
    TAKAYA, S
    VANTHIEL, D
    STARZL, TE
    TRANSPLANTATION PROCEEDINGS, 1993, 25 (01) : 628 - 634
  • [43] Immunosuppression in auxiliary partial liver transplantation with FK506 in rats
    Hossain, MA
    Hamamoto, I
    Kobayashi, S
    Maeba, T
    Maeta, H
    TRANSPLANTATION PROCEEDINGS, 1997, 29 (08) : 3617 - 3618
  • [44] FK506 for primary and rescue therapy following liver transplantation
    Platz, KP
    Mueller, AR
    Zytowski, M
    Lobeck, H
    Neuhaus, P
    TRANSPLANTATION PROCEEDINGS, 1998, 30 (04) : 1409 - 1410
  • [45] FK506 (TACROLIMUS) COMPARED WITH CYCLOSPORINE FOR PRIMARY IMMUNOSUPPRESSION AFTER PEDIATRIC LIVER-TRANSPLANTATION - RESULTS FROM THE US MULTICENTER TRIAL
    MCDIARMID, SV
    BUSUTTIL, RW
    ASCHER, NL
    BURDICK, J
    DALESSANDRO, AM
    ESQUIVEL, C
    KALAYOGLU, M
    KLEIN, AS
    MARSH, JW
    MILLER, CM
    SCHWARTZ, ME
    SHAW, BW
    SO, SK
    TRANSPLANTATION, 1995, 59 (04) : 530 - 536
  • [46] MAJOR INFECTIOUS COMPLICATIONS AFTER ORTHOTOPIC LIVER-TRANSPLANTATION AND COMPARISON OF OUTCOMES IN PATIENTS RECEIVING CYCLOSPORINE OR FK506 AS PRIMARY IMMUNOSUPPRESSION
    HADLEY, S
    SAMORE, MH
    LEWIS, WD
    JENKINS, RL
    KARCHMER, AW
    HAMMER, SM
    TRANSPLANTATION, 1995, 59 (06) : 851 - 859
  • [47] ADULT PRIMARY ORTHOTOPIC LIVER-TRANSPLANTATION UNDER FK506 - 4 YEAR FOLLOW-UP
    JAIN, A
    FUNG, JJ
    TODO, S
    RAMOS, H
    SELBY, R
    IRISH, W
    REYES, J
    JABBOUR, N
    VENKATARAMANAN, R
    STARZL, TE
    HEPATOLOGY, 1994, 20 (04) : A137 - A137
  • [48] THE IMPACT OF IMMUNOSUPPRESSIVE REGIMENS ON THE COST OF LIVER-TRANSPLANTATION - RESULTS FROM THE US FK506 MULTICENTER TRIAL
    LAKE, JR
    GORMAN, KJ
    ESQUIVEL, CO
    WIESNER, RH
    KLINTMALM, GB
    MILLER, CM
    SHAW, BW
    GORDON, JA
    TRANSPLANTATION, 1995, 60 (10) : 1089 - 1095
  • [49] VASOCONSTRICTION DIFFERS BETWEEN THE SYSTEMIC AND RENAL CIRCULATION DURING FK506 RX COMPARED TO CYCLOSPORINE (CSA) AFTER LIVER-TRANSPLANTATION
    TEXTOR, SC
    WIESNER, RH
    PORAYKO, MK
    DICKSON, ER
    WILSON, DJ
    KROM, RA
    HEPATOLOGY, 1991, 14 (04) : A50 - A50
  • [50] Central pontine myelinolysis (CPM) associated with tacrolimus (FK506) after liver transplantation
    Fukazawa, Kyota
    Nishida, Seigo
    Aguina, Luz M.
    Pretto, Ernesto A., Jr.
    ANNALS OF TRANSPLANTATION, 2011, 16 (03) : 139 - 142
12345